BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib. Leyte-Vidal A, Garrido Ruiz D, DeFilippis R, Leske IB, et al. Blood 2024;144:639-645.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Leyte-Vidal A, Garrido Ruiz D, DeFilippis R, Leske IB, et al. BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib. Blood 2024;144:639-645.
PMID: 38643492